(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOBIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ONCOBIX

ST13

US500000079325451

Class

5

Filing

79325451

Registration

7070573

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

03/30/2024

Trademark type

Combined

Nice classes

5

Filing date

10/12/2021

Registration date

06/06/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/06/2023

Last transaction

06/06/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

KR

Examiner

RINKER, ANTHONY MICHAEL

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized term "ONCOBIX."

Holders and representatives

Holders

ONCOBIX CO., LTD.

Representatives

Kwang Yup Chae Hauptman Ham, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the treatment of cancer; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical preparations for diagnosing cancer; Antibiotic preparations; Veterinary preparationsdiagnostic preparations for veterinary purposes; Pharmaceutical preparations for activating cellular function; human vaccine preparations; Anti-cancer preparations; Veterinary vaccines; Pharmaceutical agents for treating physically caused lesions; Bacteriological preparations for medical and veterinary use; Preparations of microorganisms for medical purposes; Bacterial preparations for medical purposes

Publications

History of USPTO decisions and trademark events.

43 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/30/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/03/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/06/2023

FIMP

FINAL DISPOSITION PROCESSED

09/06/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/06/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/06/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/01/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/12/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/12/2023

GPNX

NOTIFICATION PROCESSED BY IB

03/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/21/2023

PUBO

PUBLISHED FOR OPPOSITION

03/21/2023

RFNT

REFUSAL PROCESSED BY IB

03/06/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/01/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/10/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

02/10/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/10/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

02/10/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/10/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/07/2023

GNRT

NON-FINAL ACTION E-MAILED

02/07/2023

CNRT

NON-FINAL ACTION WRITTEN

02/07/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/02/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/02/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/02/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/29/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/29/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/29/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/29/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/29/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/29/2022

RFNT

REFUSAL PROCESSED BY IB

08/23/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/03/2022

RFRR

REFUSAL PROCESSED BY MPU

08/03/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/19/2022

CNRT

NON-FINAL ACTION WRITTEN

07/18/2022

DOCK

ASSIGNED TO EXAMINER

07/18/2022

MAFR

APPLICATION FILING RECEIPT MAILED

11/19/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/15/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/11/2021

Continuous trademark protection

Get notified about every new filing that threatens ONCOBIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.